- Home
- INBX vs AIIR Comparison
INBX vs AIIR Comparison
Compare INBX & AIIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | AIIR |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | INBX | AIIR |
|---|---|---|
| Price | $103.63 | $7.74 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $150.00 | N/A |
| AVG Volume (30 Days) | ★ 196.7K | 8.8K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $26.19 | $5.29 |
| 52 Week High | $155.29 | $8.64 |
Technical Indicators
Market Signals| Indicator | INBX | AIIR |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 58.06 |
| Support Level | $99.20 | $6.50 |
| Resistance Level | $106.40 | $8.40 |
| Average True Range (ATR) | 6.20 | 0.67 |
| MACD | 1.75 | 0.10 |
| Stochastic Oscillator | 86.65 | 56.84 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About AIIR Air Global PLC Ordinary Shares
AIR Global PLC operates in the social inhalation products sector and has operations across multiple international markets. Its portfolio includes businesses and products related to shisha and hookah, including flavored shisha molasses, hookah and shisha e-commerce platforms, and charcoal-free shisha devices. The company also conducts product research and testing in partnership with independent laboratories to support the development of inhalation-related products and technologies.